Stockley Park, UK – 24 April 2023 – Kite, a Gilead Company, today announces the publication of a new European analysis of commercial manufacturing experience of Yescarta ® (axicabtagene ciloleucel or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results